Veracyte, Inc. · 5 hours ago
Director of Investor Relations
Veracyte, Inc. is a global diagnostics company committed to transforming cancer care for patients across the globe. The Director of Investor Relations will serve as a strategic partner to executive leadership, responsible for developing and executing the company's investor relations strategy and ensuring compelling financial communications to the investment community.
BiotechnologyHealth CareHealth Diagnostics
Responsibilities
Develop and execute the company’s investor relations strategy aligned with long‑term business goals
Own the company’s external financial communications
Prepare executive leadership for investor meetings, roadshows, and conferences
Maintain a deep understanding of the company’s business and industry landscape
Monitor investor feedback, stock performance, analyst sentiment, and market trends
Lead creation of quarterly earnings materials including scripts, presentations, and press releases
Collaborate with Finance, FP&A, Accounting, Legal, and Executive teams
Draft investor‑facing content including annual reports and ESG‑related disclosures
Serve as primary liaison for investors and analysts
Build a diversified investor base
Coordinate investor conferences, NDRs, and one‑on‑one meetings
Track analyst models and consensus estimates
Partner with Communications, Legal, and HR for consistent messaging
Support Board updates on investor sentiment and market trends
Provide insights to Finance and FP&A teams
Qualification
Required
10 years of experience in IR, equity research, investment banking, corporate finance, or FP&A
Strong understanding of financial statements and capital markets
Exceptional communication skills
Proven investor‑facing experience
Advanced proficiency in Excel, PowerPoint, and financial modeling
Preferred
Experience in life sciences, diagnostics, biotech, or healthcare
Familiarity with ESG frameworks
Experience with quarterly earnings cycles
Benefits
Competitive compensation and benefits
Additional discretionary bonuses/incentives
Restricted stock units
Company
Veracyte, Inc.
Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer.
H1B Sponsorship
Veracyte, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (8)
2024 (17)
2023 (7)
2022 (2)
2021 (6)
2020 (8)
Funding
Current Stage
Public CompanyTotal Funding
$1.1BKey Investors
Visium Healthcare PartnersGE VenturesDomain Associates
2021-02-05Post Ipo Equity· $550M
2020-08-05Post Ipo Equity· $194M
2019-05-01Post Ipo Equity· $137.8M
Recent News
2026-01-12
TradingView
2026-01-12
Company data provided by crunchbase